Hillsdale Investment Management’s Hims & Hers Health HIMS Stock Holding History

Hillsdale Investment Management’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-145,810	Closed	-$7.27M	–	685
2025 Q2	$7.27M	Buy	145,810 +17,810	+14%	+$805K	0.27%	64
2025 Q1	$3.78M	Sell	128,000 -86,500	-40%	-$3.21M	0.19%	128
2024 Q4	$5.19M	Sell	214,500 -48,100	-18%	-$1.19M	0.26%	71
2024 Q3	$4.84M	Sell	262,600 -700	-0.3%	-$12.5K	0.37%	72
2024 Q2	$5.32M	Sell	263,300 -19,050	-7%	-$317K	0.42%	56
2024 Q1	$4.37M	Sell	282,350 -1,300	-0.5%	-$14.7K	0.35%	96
2023 Q4	$2.52M	Sell	283,650 -145,650	-34%	-$1.08M	0.21%	173
2023 Q3	$2.7M	Buy	429,300 +230	+0.1%	+$1.71K	0.25%	150
2023 Q2	$4.03M	Sell	429,070 -68,530	-14%	-$679K	0.37%	109
2023 Q1	$4.94M	Buy	+497,600	New	+$4.36M	0.42%	79

Other funds holding HIMS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hillsdale Investment Management's HIMS Position: Q3 2025 in Review

Hillsdale Investment Management sold out of Hims & Hers Health (HIMS) in Q3 2025, closing a stake of 145,810 shares — an estimated $7.27M sold.

Hillsdale Investment Management first reported a position in HIMS in Q1 2023 and held it in 10 quarters. The position peaked at $7.27M in Q2 2025. 512 funds tracked by Wall St. Rank hold HIMS as of Q3 2025.

Hillsdale Investment Management reported no remaining Hims & Hers Health position as of Q3 2025 after selling out during the quarter.
Hillsdale Investment Management sold 145,810 Hims & Hers Health shares in Q3 2025, an estimated $7.27M.
Hillsdale Investment Management first reported a position in Hims & Hers Health in Q1 2023 and held it in 10 quarters.
Hillsdale Investment Management's Hims & Hers Health position peaked at $7.27M in Q2 2025.
512 funds tracked by Wall St. Rank held Hims & Hers Health as of Q3 2025.

Based on Hillsdale Investment Management's 13F filing for Q3 2025, filed 10 Nov 2025.